{"id":"https://openalex.org/W2778864652","doi":"https://doi.org/10.1183/1393003.congress-2017.pa4684","title":"The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice","display_name":"The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice","publication_year":2017,"publication_date":"2017-09-01","ids":{"openalex":"https://openalex.org/W2778864652","doi":"https://doi.org/10.1183/1393003.congress-2017.pa4684","mag":"2778864652"},"language":"en","primary_location":{"id":"doi:10.1183/1393003.congress-2017.pa4684","doi":"https://doi.org/10.1183/1393003.congress-2017.pa4684","is_oa":false,"landing_page_url":"https://doi.org/10.1183/1393003.congress-2017.pa4684","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway Pharmacology and Treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068551337","display_name":"Barbara Dymek","orcid":"https://orcid.org/0000-0002-1003-2538","observed_orcids":["https://orcid.org/0000-0002-1003-2538"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Barbara Dymek","raw_affiliation_strings":["OncoArendi Therapeutics SA, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067940514","display_name":"Piotr L. Sklepkiewicz","orcid":"https://orcid.org/0000-0001-6957-5812","observed_orcids":["https://orcid.org/0000-0001-6957-5812"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Piotr Sklepkiewicz","raw_affiliation_strings":["OncoArendi Therapeutics SA, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065207208","display_name":"Magdalena Salamon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Magdalena Salamon","raw_affiliation_strings":["OncoArendi Therapeutics SA, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007448315","display_name":"Anna Maria Zdziarska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Anna Maria Zdziarska","raw_affiliation_strings":["OncoArendi Therapeutics SA, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047935758","display_name":"Micha\u0142 Ml\u0105cki","orcid":"https://orcid.org/0000-0002-4034-6933","observed_orcids":["https://orcid.org/0000-0002-4034-6933"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Micha\u0142 Ml\u0105cki","raw_affiliation_strings":["OncoArendi Therapeutics SA, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027478554","display_name":"Agnieszka Zago\u017cd\u017con","orcid":"https://orcid.org/0000-0001-6200-4355","observed_orcids":["https://orcid.org/0000-0001-6200-4355"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Agnieszka Zago\u017cd\u017con","raw_affiliation_strings":["OncoArendi Therapeutics SA, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035940553","display_name":"Robert Koralewski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Robert Koralewski","raw_affiliation_strings":["OncoArendi Therapeutics SA, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089223533","display_name":"Marzena Mazur","orcid":"https://orcid.org/0000-0002-4766-0482","observed_orcids":["https://orcid.org/0000-0002-4766-0482"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Marzena Mazur","raw_affiliation_strings":["OncoArendi Therapeutics SA, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021496114","display_name":"Adam Go\u0142\u0229biowski","orcid":"https://orcid.org/0000-0001-5960-2995","observed_orcids":["https://orcid.org/0000-0001-5960-2995"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Adam Go\u0142\u0119biowski","raw_affiliation_strings":["OncoArendi Therapeutics SA, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038751267","display_name":"Jakub Go\u0142\u0105b","orcid":"https://orcid.org/0000-0002-2830-5100","observed_orcids":["https://orcid.org/0000-0002-2830-5100"]},"institutions":[{"id":"https://openalex.org/I268303160","display_name":"Medical University of Warsaw","ror":"https://ror.org/04p2y4s44","country_code":"PL","type":"education","lineage":["https://openalex.org/I268303160"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Jakub Go\u0142\u0105b","raw_affiliation_strings":["Department of Immunology, Medical University of Warsaw, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Medical University of Warsaw, Warsaw, Poland","institution_ids":["https://openalex.org/I268303160"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062063050","display_name":"Karolina Dzwonek","orcid":"https://orcid.org/0000-0002-9580-3863","observed_orcids":["https://orcid.org/0000-0002-9580-3863"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Karolina Dzwonek","raw_affiliation_strings":["OncoArendi Therapeutics SA, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA4684","last_page":"PA4684"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.5644999742507935,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.5644999742507935,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12683","display_name":"Studies on Chitinases and Chitosanases","score":0.426800012588501,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acidic-mammalian-chitinase","display_name":"acidic mammalian chitinase","score":0.8299999833106995},{"id":"https://openalex.org/keywords/chitotriosidase","display_name":"chitotriosidase","score":0.996999979019165},{"id":"https://openalex.org/keywords/chitinase-inhibitors","display_name":"chitinase inhibitors","score":0.875},{"id":"https://openalex.org/keywords/montelukast","display_name":"montelukast","score":0.9440000057220459},{"id":"https://openalex.org/keywords/house-dust-mites","display_name":"house dust mites","score":0.7369999885559082},{"id":"https://openalex.org/keywords/allergic-airway-inflammation","display_name":"allergic airway inflammation","score":0.7919999957084656},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.8889999985694885},{"id":"https://openalex.org/keywords/chronic-airway-inflammation","display_name":"chronic airway inflammation","score":0.7670000195503235},{"id":"https://openalex.org/keywords/chitinolytic-activity","display_name":"chitinolytic activity","score":0.8379999995231628},{"id":"https://openalex.org/keywords/ige","display_name":"IgE","score":0.7279999852180481},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C2776322731","wikidata":"https://www.wikidata.org/wiki/Q417767","display_name":"Montelukast","level":3,"score":0.9886634349822998},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8555834293365479},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.6743688583374023},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5495126843452454},{"id":"https://openalex.org/C2778166374","wikidata":"https://www.wikidata.org/wiki/Q29938","display_name":"House dust mite","level":4,"score":0.5163325071334839},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4900599718093872},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4599570035934448},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.4529239237308502},{"id":"https://openalex.org/C2776452501","wikidata":"https://www.wikidata.org/wiki/Q424190","display_name":"Leukotriene","level":3,"score":0.43465322256088257},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4275379180908203},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.2976120710372925},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2627077102661133},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17192336916923523},{"id":"https://openalex.org/C2780510475","wikidata":"https://www.wikidata.org/wiki/Q186752","display_name":"Allergen","level":3,"score":0.14383792877197266}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/1393003.congress-2017.pa4684","doi":"https://doi.org/10.1183/1393003.congress-2017.pa4684","is_oa":false,"landing_page_url":"https://doi.org/10.1183/1393003.congress-2017.pa4684","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway Pharmacology and Treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W2032895858","https://openalex.org/W2072705074"],"related_works":["https://openalex.org/W2781427521","https://openalex.org/W4322743010","https://openalex.org/W1988338353","https://openalex.org/W2172332643","https://openalex.org/W2015814027","https://openalex.org/W2121775309","https://openalex.org/W2362399667","https://openalex.org/W2368657598","https://openalex.org/W2144831051","https://openalex.org/W2386792928"],"abstract_inverted_index":{"Introduction:":[0],"Acidic":[1],"mammalian":[2],"chitinase":[3],"(AMCase)":[4],"and":[5,21,48,88,113,149,161,177,198,202],"chitotriosidase":[6],"(CHIT1)":[7],"are":[8],"enzymatically":[9],"active":[10,116],"chitinases":[11,172],"implicated":[12],"in":[13,42,64,71,117,141,159,168,173,206,218,223],"pathology":[14],"of":[15,26,35,80,104,139,146,156,171,188,239],"respiratory":[16],"disorders":[17],"such":[18],"as":[19,60,133,163,165],"asthma":[20,124,221],"COPD.":[22],"Objectives:":[23],"The":[24,67,143,192],"aim":[25],"the":[27,32,43,81,100,105,122,136,181,189,211,219,237],"study":[28],"was":[29,73],"to":[30,49,131,216],"evaluate":[31],"therapeutic":[33],"efficacy":[34],"OAT-889,":[36],"a":[37,61,76,94,110,153,228,232],"novel":[38],"dual":[39,111,233],"AMCase/CHIT1":[40,234],"inhibitor":[41,115,235],"chronic":[44,68,123,220],"airway":[45,69,196],"inflammation":[46,70,197],"model":[47,125,222],"compare":[50],"it":[51],"with":[52,152,166],"montelukast,":[53,217],"an":[54],"oral":[55],"leukotriene":[56],"receptor":[57],"antagonist":[58],"used":[59],"maintenance":[62],"therapy":[63],"asthma.":[65,240],"Methods:":[66],"mice":[72],"induced":[74],"by":[75,135],"7-week-long":[77],"intranasal":[78],"administration":[79],"house":[82],"dust":[83],"mite":[84],"(HDM)":[85],"extract.":[86],"OAT-889":[87,108,126,148,176,201,209],"montelukast":[89,132,150,178,203],"were":[90],"administered":[91],"p.o.":[92],"once":[93],"day":[95],"at":[96],"30":[97],"mg/kg":[98],"for":[99,230,236],"last":[101],"three":[102],"weeks":[103],"study.":[106],"Results:":[107],"is":[109,205],"AMCase":[112],"CHIT1":[114],"low":[118],"nanomolar":[119],"range.":[120],"In":[121],"exhibited":[127],"anti-inflammatory":[128,144,213],"activity":[129,158],"superior":[130,215],"shown":[134],"total":[137,169,182],"number":[138],"cells":[140],"BAL.":[142,174],"effects":[145],"both":[147],"correlated":[151],"significant":[154],"reduction":[155],"chitinolytic":[157],"BAL":[160],"serum":[162,183],"well":[164],"decrease":[167],"amount":[170],"Additionally,":[175],"comparably":[179],"reduced":[180],"IgE":[184],"concentration":[185],"indicating":[186],"suppression":[187],"allergic":[190],"response.":[191],"histopathological":[193],"analysis":[194],"assessing":[195],"remodeling":[199],"after":[200],"treatment":[204,238],"progress.":[207],"Conclusions:":[208],"demonstrated":[210],"profound":[212],"effect,":[214],"mice.":[224],"These":[225],"results":[226],"provide":[227],"rationale":[229],"developing":[231]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-01-05T00:00:00"}
